Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy Palzkill

Showing results (11-20 of 142) with videos related to

Pageof 15
Sort By:
Current Opinion in Structural Biology|July 3, 2023
Structural biology of MCR-1-mediated resistance to polymyxin antibioticsIsabel Cristina Materon, Timothy Palzkill
Genetics|March 6, 2003
An analysis of why highly similar enzymes evolve differentlyFahd K Majiduddin, Timothy Palzkill
Methods in Molecular Biology (Clifton, N.J.)|June 26, 2003
Minimization of proteins by random fragmentation and selectionGary W Rudgers, Timothy Palzkill
Biochemistry|February 10, 2017
BLIP-II Employs Differential Hotspot Residues To Bind Structurally Similar Staphylococcus aureus PBP2a and Class A β-LactamasesCarolyn J Adamski, Timothy Palzkill
Antimicrobial Agents and Chemotherapy|January 23, 2024
The mechanism of ceftazidime and cefiderocol hydrolysis by D179Y variants of KPC carbapenemases is similar and involves the formation of a long-lived covalent intermediateAndre Birgy, Christina Nnabuife, Timothy Palzkill
Plos Pathogens|June 2, 2015
Natural Variants of the KPC-2 Carbapenemase have Evolved Increased Catalytic Efficiency for Ceftazidime Hydrolysis at the Cost of Enzyme StabilityShrenik C Mehta, Kacie Rice, Timothy Palzkill
The Journal of Biological Chemistry|October 9, 2008
Structural insight into the kinetics and DeltaCp of interactions between TEM-1 beta-lactamase and beta-lactamase inhibitory protein (BLIP)Jihong Wang, Timothy Palzkill, Dar-Chone Chow
ACS Medicinal Chemistry Letters|June 6, 2014
Neutral β-Lactams Inactivate High Molecular Mass Penicillin-Binding Proteins of Class B1, Including PBP2a of MRSAKinjal Dave, Timothy Palzkill, R F Pratt
Methods (San Diego, Calif.)|August 16, 2006
Using peptide arrays to define nuclear carrier binding sites on nucleoporinsIan Cushman, Timothy Palzkill, Mary Shannon Moore
Antimicrobial Agents and Chemotherapy|January 30, 2026
Phosphate sensitivity of KPC-2: a hidden variable in β-lactamase kineticsDignite F Ngango, André Birgy, Timothy Palzkill
Pageof 15

Showing results (11-20 of 142) with videos related to

Sort By:
Pageof 15
Current Opinion in Structural Biology|July 3, 2023
Structural biology of MCR-1-mediated resistance to polymyxin antibioticsIsabel Cristina Materon, Timothy Palzkill
Genetics|March 6, 2003
An analysis of why highly similar enzymes evolve differentlyFahd K Majiduddin, Timothy Palzkill
Methods in Molecular Biology (Clifton, N.J.)|June 26, 2003
Minimization of proteins by random fragmentation and selectionGary W Rudgers, Timothy Palzkill
Biochemistry|February 10, 2017
BLIP-II Employs Differential Hotspot Residues To Bind Structurally Similar Staphylococcus aureus PBP2a and Class A β-LactamasesCarolyn J Adamski, Timothy Palzkill
Antimicrobial Agents and Chemotherapy|January 23, 2024
The mechanism of ceftazidime and cefiderocol hydrolysis by D179Y variants of KPC carbapenemases is similar and involves the formation of a long-lived covalent intermediateAndre Birgy, Christina Nnabuife, Timothy Palzkill
Plos Pathogens|June 2, 2015
Natural Variants of the KPC-2 Carbapenemase have Evolved Increased Catalytic Efficiency for Ceftazidime Hydrolysis at the Cost of Enzyme StabilityShrenik C Mehta, Kacie Rice, Timothy Palzkill
The Journal of Biological Chemistry|October 9, 2008
Structural insight into the kinetics and DeltaCp of interactions between TEM-1 beta-lactamase and beta-lactamase inhibitory protein (BLIP)Jihong Wang, Timothy Palzkill, Dar-Chone Chow
ACS Medicinal Chemistry Letters|June 6, 2014
Neutral β-Lactams Inactivate High Molecular Mass Penicillin-Binding Proteins of Class B1, Including PBP2a of MRSAKinjal Dave, Timothy Palzkill, R F Pratt
Methods (San Diego, Calif.)|August 16, 2006
Using peptide arrays to define nuclear carrier binding sites on nucleoporinsIan Cushman, Timothy Palzkill, Mary Shannon Moore
Antimicrobial Agents and Chemotherapy|January 30, 2026
Phosphate sensitivity of KPC-2: a hidden variable in β-lactamase kineticsDignite F Ngango, André Birgy, Timothy Palzkill
Pageof 15